Regina Elena Cancer Institute Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Rimini Italy (1933)

Organization Overview

First Clinical Trial
2004
NCT00559026
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Department of Anaesthesiology, Regina Elena, National Cancer Institute, Via Elio Chianesi 53, 00144 Roma (Italy); Tel. +39 0652662942, FAX: +39 0652662993; e-mail: forastiere@ifo.it | Marco G Paggi, MD, PhD | Regina Elena Cancer Institute | Regina Elena National Cancer Institute Via Elio Chianesi 53, 00144 Rome, Italy

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Glioblastoma (Phase 2)

Melanoma (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 15